EHA Takes Early Action on EU’s Forthcoming Biotech Act: Biotechnology Wonders 2026
The European Hematology Association (EHA) recently shared a post on X:
”The EU is developing new legislation that will impact hematology – the Biotech Act.
EHA ensures that hematologists are represented in this process.”
Read the preliminary recommendations for a Biotech Act here.
In 2024, the European Commission launched preparatory work on a landmark piece of legislation—the Biotech Act—set to be formally proposed in 2026.
Aimed at streamlining the development and market access of biotech products, the regulation also seeks to uphold high safety standards while bolstering the competitiveness and scale of the EU’s biotechnology sector.
Although the legislative text is still in the works, key stakeholders are already mobilizing.
The European Hematology Association (EHA) has actively stepped in to ensure the voice of hematologists is heard from the outset.
Through early advocacy and strategic engagement, EHA is positioning the hematology community to help shape a regulatory environment that supports innovation while protecting patient safety.
As the Biotech Act progresses, EHA remains committed to representing the field throughout every phase of the EU legislative process.
Latest updates in the World of Hematology featured in Hemostasis Today.
-
Jul 11, 2025, 19:14ISTH 2025 for Cardiac Surgery: LEX-211 (FARES-II) Trial Shows Promising Results
-
Jul 11, 2025, 16:48GPAS 2025: Shaping the Future of Bleeding Disorder Care
-
Jul 10, 2025, 11:23HTRS Thanks CSL Behring for Its Ongoing Commitment to Research Support
-
Jul 9, 2025, 14:11Join Dr. Bethany Samuelson Bannow for a Virtual Event on Hemostasis and Cancer
-
Jul 9, 2025, 13:59Late-Breaking Insights from ISTH 2025: Rurioctocog Alfa Pegol in PUPs with Hemophilia A
-
Jul 12, 2025, 16:21Richard Buka։ Evolution’s Imprint on Blood, Natural Selection Shaping Today’s Hematologic Disorders
-
Jul 12, 2025, 15:337 Tesla MRI Sheds Light on END Mechanisms in Symptomatic MCA Stenosis
-
Jul 12, 2025, 15:221 in 100: Subclavian Steal Syndrome Revealed by LVO Stroke in Case with Persistent Trigeminal Artery
-
Jul 11, 2025, 18:50ICAS Not a Factor: Post-EVT Intensive BP Control within 24 hrs Worsens Outcomes
-
Jul 11, 2025, 17:57Need for Recanalization Strategies Reinforced in P1 and P2: PCA Stroke Poor Outcomes
-
Jul 7, 2025, 17:08Detecting Anti-Drug Antibodies to Emicizumab: A French Center’s Remarkable Experience
-
Jul 6, 2025, 21:00From Untouchable to Editable: How 21st-Century Gene Editing Breakthroughs Clash with Systemic Barriers
-
Mar 6, 2025, 17:15Olympus Announces Launch of Single-Use Hemostasis Clip
-
Jul 10, 2025, 18:25Dr. Carol Kasper: Honoring the Legacy
-
Jul 8, 2025, 08:26ASH and HVO Collaborate to Expand Hematology Training in LMICs
-
Jul 6, 2025, 15:02Patients as Experts: EHC Calls for Early Involvement in HTA Systems
-
Jul 6, 2025, 14:56Missed ISTH 2025? Congress Daily Has You Covered
-
Jul 6, 2025, 11:48Japan's Youth Engagement in Hemophilia Care: Where Even the Doctors Get It – HABIT Summit 2025